Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
FASEB J
2012 Oct 01;2610:4348-59. doi: 10.1096/fj.12-207431.
Show Gene links
Show Anatomy links
Identification of SPLUNC1's ENaC-inhibitory domain yields novel strategies to treat sodium hyperabsorption in cystic fibrosis airways.
Hobbs CA
,
Blanchard MG
,
Kellenberger S
,
Bencharit S
,
Cao R
,
Kesimer M
,
Walton WG
,
Redinbo MR
,
Stutts MJ
,
Tarran R
.
???displayArticle.abstract???
The epithelial sodium channel (ENaC) is responsible for Na+ and fluid absorption across colon, kidney, and airway epithelia. We have previously identified SPLUNC1 as an autocrine inhibitor of ENaC. We have now located the ENaC inhibitory domain of SPLUNC1 to SPLUNC1's N terminus, and a peptide corresponding to this domain, G22-A39, inhibited ENaC activity to a similar degree as full-length SPLUNC1 (∼2.5 fold). However, G22-A39 had no effect on the structurally related acid-sensing ion channels, indicating specificity for ENaC. G22-A39 preferentially bound to the β-ENaC subunit in a glycosylation-dependent manner. ENaC hyperactivity is contributory to cystic fibrosis (CF) lung disease. Addition of G22-A39 to CF human bronchial epithelial cultures (HBECs) resulted in an increase in airway surface liquid height from 4.2±0.6 to 7.9±0.6 μm, comparable to heights seen in normal HBECs, even in the presence of neutrophil elastase. Our data also indicate that the ENaC inhibitory domain of SPLUNC1 may be cleaved away from the main molecule by neutrophil elastase, which suggests that it may still be active during inflammation or neutrophilia. Furthermore, the robust inhibition of ENaC by the G22-A39 peptide suggests that this peptide may be suitable for treating CF lung disease.
,
Retraction.
2013,
Pubmed
Anantharam,
Open probability of the epithelial sodium channel is regulated by intracellular sodium.
2006,
Pubmed
,
Xenbase
Askwith,
Neuropeptide FF and FMRFamide potentiate acid-evoked currents from sensory neurons and proton-gated DEG/ENaC channels.
2000,
Pubmed
,
Xenbase
Bartlett,
PLUNC: a multifunctional surfactant of the airways.
2011,
Pubmed
Bingle,
Differential epithelial expression of the putative innate immune molecule SPLUNC1 in cystic fibrosis.
2007,
Pubmed
Blanchard,
Effect of a temperature increase in the non-noxious range on proton-evoked ASIC and TRPV1 activity.
2011,
Pubmed
Bray,
Flexible peptides and cytoplasmic gels.
2005,
Pubmed
Bridges,
Transepithelial measurements of bicarbonate secretion in Calu-3 cells.
2002,
Pubmed
Bruns,
Epithelial Na+ channels are fully activated by furin- and prostasin-dependent release of an inhibitory peptide from the gamma-subunit.
2007,
Pubmed
,
Xenbase
Buchan,
Protein annotation and modelling servers at University College London.
2010,
Pubmed
Canessa,
Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits.
1994,
Pubmed
,
Xenbase
Canessa,
Membrane topology of the epithelial sodium channel in intact cells.
1994,
Pubmed
,
Xenbase
Carattino,
The epithelial Na+ channel is inhibited by a peptide derived from proteolytic processing of its alpha subunit.
2006,
Pubmed
,
Xenbase
Carattino,
Defining an inhibitory domain in the alpha-subunit of the epithelial sodium channel.
2008,
Pubmed
,
Xenbase
Chu,
Function and regulation of SPLUNC1 protein in Mycoplasma infection and allergic inflammation.
2007,
Pubmed
Diochot,
A new sea anemone peptide, APETx2, inhibits ASIC3, a major acid-sensitive channel in sensory neurons.
2004,
Pubmed
,
Xenbase
Donaldson,
Regulation of the epithelial sodium channel by serine proteases in human airways.
2002,
Pubmed
,
Xenbase
Gally,
SPLUNC1 promotes lung innate defense against Mycoplasma pneumoniae infection in mice.
2011,
Pubmed
Garcia-Caballero,
SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavage.
2009,
Pubmed
,
Xenbase
Garty,
Epithelial sodium channels: function, structure, and regulation.
1997,
Pubmed
Haynes,
Hydroxyurea attenuates activated neutrophil-mediated sickle erythrocyte membrane phosphatidylserine exposure and adhesion to pulmonary vascular endothelium.
2008,
Pubmed
Hughey,
Maturation of the epithelial Na+ channel involves proteolytic processing of the alpha- and gamma-subunits.
2003,
Pubmed
,
Xenbase
Jones,
Protein secondary structure prediction based on position-specific scoring matrices.
1999,
Pubmed
Kashlan,
Constraint-based, homology model of the extracellular domain of the epithelial Na+ channel α subunit reveals a mechanism of channel activation by proteases.
2011,
Pubmed
Kashlan,
Allosteric inhibition of the epithelial Na+ channel through peptide binding at peripheral finger and thumb domains.
2010,
Pubmed
,
Xenbase
Kay,
The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains.
2000,
Pubmed
Kesimer,
Mass spectrometric analysis of mucin core proteins.
2012,
Pubmed
Kesimer,
Tracheobronchial air-liquid interface cell culture: a model for innate mucosal defense of the upper airways?
2009,
Pubmed
Knowles,
Mucus clearance as a primary innate defense mechanism for mammalian airways.
2002,
Pubmed
McGillivary,
The multifunctional host defense peptide SPLUNC1 is critical for homeostasis of the mammalian upper airway.
2010,
Pubmed
Poirot,
Selective regulation of acid-sensing ion channel 1 by serine proteases.
2004,
Pubmed
,
Xenbase
Randell,
Primary epithelial cell models for cystic fibrosis research.
2011,
Pubmed
Ratjen,
Restoring airway surface liquid in cystic fibrosis.
2006,
Pubmed
Renard,
Biochemical analysis of the membrane topology of the amiloride-sensitive Na+ channel.
1994,
Pubmed
,
Xenbase
Rollins,
SPLUNC1 expression reduces surface levels of the epithelial sodium channel (ENaC) in Xenopus laevis oocytes.
2010,
Pubmed
,
Xenbase
Rossier,
Activation of the epithelial sodium channel (ENaC) by serine proteases.
2009,
Pubmed
Rowe,
Cystic fibrosis.
2005,
Pubmed
Roxo-Rosa,
Proteomic analysis of nasal cells from cystic fibrosis patients and non-cystic fibrosis control individuals: search for novel biomarkers of cystic fibrosis lung disease.
2006,
Pubmed
Sherwood,
Dynorphin opioid peptides enhance acid-sensing ion channel 1a activity and acidosis-induced neuronal death.
2009,
Pubmed
,
Xenbase
Snyder,
Liddle's syndrome mutations disrupt cAMP-mediated translocation of the epithelial Na(+) channel to the cell surface.
2000,
Pubmed
Stutts,
CFTR as a cAMP-dependent regulator of sodium channels.
1995,
Pubmed
Tarran,
The CF salt controversy: in vivo observations and therapeutic approaches.
2001,
Pubmed
Tarran,
Soluble mediators, not cilia, determine airway surface liquid volume in normal and cystic fibrosis superficial airway epithelia.
2006,
Pubmed
Voynow,
Proteases and cystic fibrosis.
2008,
Pubmed
Yan,
N-linked glycosylation is critical for the plasma membrane localization of nephrin.
2002,
Pubmed
Zhou,
Effect of SPLUNC1 protein on the Pseudomonas aeruginosa and Epstein-Barr virus.
2008,
Pubmed
